Recent data have supported the addition of the sodium-glucose cotransporter-2 (SGLT-2) inhibitors as a foundational therapy to improve survival and health status in patients with heart failure (HF) with reduction ejection fraction ([1][1]) ([Online References 1,2][2]). All 6 life-prolonging
ABSTRACTBackgroundPatients with heart failure (HF) are limited by symptoms and have impaired quality of life. The Kansas City Cardiomyopathy Questionnaire (KCCQ) is a patient-reported outcome…
Nature Medicine – This participant-level pooled analysis of the three phase 3 trials that have tested the non-steroidal mineralocorticoid receptor antagonist finerenone in patients with…
Nature Medicine – This participant-level pooled analysis of the three phase 3 trials that have tested the non-steroidal mineralocorticoid receptor antagonist finerenone in patients with…
Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA Brigham and Women’s Hospital, Harvard…
Actions of angiotensin II may contribute to the progression of heart failure despite treatment with currently recommended drugs. We therefore evaluated the long-term effects of…
View all available purchase options and get full access to this article. Request permissions for this article. Department of Medicine, Division of Nephrology, Richard L.…
View all available purchase options and get full access to this article. Request permissions for this article. Department of Medicine, Division of Nephrology, Richard L.…
View all available purchase options and get full access to this article. Request permissions for this article. Department of Medicine, Division of Nephrology, Richard L.…
View all available purchase options and get full access to this article. Request permissions for this article. Department of Medicine, Division of Nephrology, Richard L.…
View all available purchase options and get full access to this article. Request permissions for this article. Department of Medicine, Division of Nephrology, Richard L.…
